Bio Vitos Pharma Balance Sheet Health
Financial Health criteria checks 4/6
Bio Vitos Pharma has a total shareholder equity of SEK26.6M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK26.9M and SEK304.0K respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 768.52k |
| Equity | SEK 26.60m |
| Total liabilities | SEK 303.97k |
| Total assets | SEK 26.90m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: BIOVIT's short term assets (SEK2.6M) exceed its short term liabilities (SEK304.0K).
Long Term Liabilities: BIOVIT has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: BIOVIT is debt free.
Reducing Debt: BIOVIT has no debt compared to 5 years ago when its debt to equity ratio was 2.7%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BIOVIT has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BIOVIT has less than a year of cash runway if free cash flow continues to grow at historical rates of 13.1% each year.